The potential roles for novel biomarkers in rheumatoid arthritis assessmentMEASE, P. J.Clinical and experimental rheumatology (Testo stampato). 2011, Vol 29, Num 3, pp 567-574, issn 0392-856X, 8 p.Article

Cytokine blockers in psoriatic arthritisMEASE, P. J.Annals of the rheumatic diseases. 2001, Vol 60, pp iii37-iii40, issn 0003-4967, SUP3Article

Safety and Efficacy of Ocrelizumab in Patients With Rheumatoid Arthritis and an Inadequate Response to at Least One Tumor Necrosis Factor Inhibitor: Results of a Forty-Eight―Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III TrialTAK, P. P; MEASE, P. J; KUMAR, S et al.Arthritis and rheumatism. 2012, Vol 64, Num 2, pp 360-370, issn 0004-3591, 11 p.Article

Seronegative spondyloarthropathies: to lump or split?NASH, P; MEASE, P. J; BRAUN, J et al.Annals of the rheumatic diseases. 2005, Vol 64, pp ii9-ii13, issn 0003-4967, SUP2Article

Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis : analysis of data from randomised controlled trials of two tumour necrosis factor inhibitorsFRANSEN, J; ANTONI, C; MEASE, P. J et al.Annals of the rheumatic diseases. 2006, Vol 65, Num 10, pp 1373-1378, issn 0003-4967, 6 p.Article

Psoriasis: epidemiology, clinical features, and quality of life. DiscussionLANGLEY, R. G. B; KRUEGER, G. G; GRIFFITHS, C. E. M et al.Annals of the rheumatic diseases. 2005, Vol 64, pp ii18-ii25, issn 0003-4967, SUP2Article

Psoriatic arthritis and imagingORY, P. A; GLADMAN, D. D; MEASE, P. J et al.Annals of the rheumatic diseases. 2005, Vol 64, pp ii55-ii57, issn 0003-4967, SUP2Article

Psoriasis assessment tools in clinical trials. DiscussionFELDMAN, S. R; KRUEGER, G. G; TAYLOR, W. J et al.Annals of the rheumatic diseases. 2005, Vol 64, pp ii65-ii73, issn 0003-4967, SUP2Article

Psoriatic arthritis clinical registries and genomicsGLADMAN, D. D; RITCHLIN, C; HELLIWELL, P. S et al.Annals of the rheumatic diseases. 2005, Vol 64, pp ii103-ii105, issn 0003-4967, SUP2Article

OMERACT 7 psoriatic arthritis workshop: synopsisGLADMAN, D. D; STRAND, V; MEASE, P. J et al.Annals of the rheumatic diseases. 2005, Vol 64, pp ii115-ii116, issn 0003-4967, SUP2Article

Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1 ra), for the treatment of rheumatic diseases, 2005FURST, D. E; BREEDVELD, F. C; MEASE, P. J et al.Annals of the rheumatic diseases. 2005, Vol 64, pp iv2-iv14, issn 0003-4967, SUP4Conference Paper

Natural history of the eosinophilia-myalgia syndromeCULPEPPER, R. C; WILLIAMS, R. G; MEASE, P. J et al.Annals of internal medicine. 1991, Vol 115, Num 6, pp 437-442, issn 0003-4819Article

Psoriasis pathophysiology: current concepts of pathogenesisKRUEGER, J. G; BOWCOCK, A.Annals of the rheumatic diseases. 2005, Vol 64, pp ii30-ii36, issn 0003-4967, SUP2Article

Science of assessmentBELLAMY, N.Annals of the rheumatic diseases. 2005, Vol 64, pp ii42-ii45, issn 0003-4967, SUP2Article

Imaging the joint and enthesis: insights into pathogenesis of psoriatic arthritisMCGONAGLE, D.Annals of the rheumatic diseases. 2005, Vol 64, pp ii58-ii60, issn 0003-4967, SUP2Article

Psoriatic arthritis therapy: NSAIDs and traditional DMARDsNASH, P; CLEGG, D. O.Annals of the rheumatic diseases. 2005, Vol 64, pp ii74-ii77, issn 0003-4967, SUP2Article

Psoriasis treatment: traditional therapyLEBWOHL, M; TING, P. T; KOO, J. Y. M et al.Annals of the rheumatic diseases. 2005, Vol 64, pp ii83-ii86, issn 0003-4967, SUP2Article

Introduction/overview on clinical registriesGLADMAN, D. D; MENTER, A.Annals of the rheumatic diseases. 2005, Vol 64, pp ii101-ii102, issn 0003-4967, SUP2Article

Etanercept therapy in rheumatoid arthritis: A randomized, controlled trialMORELAND, L. W; SCHIFF, M. H; RUDERMAN, E. M et al.Annals of internal medicine. 1999, Vol 130, Num 6, pp 478-486, issn 0003-4819Article

Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritisKATON, W. J; BUCHWALD, D. S; SIMON, G. E et al.Journal of general internal medicine. 1991, Vol 6, Num 4, pp 277-285, issn 0884-8734Article

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trialVAN DER HEIJDE, D; SCHIFF, M. H; SIEPER, J et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 6, pp 922-929, issn 0003-4967, 8 p.Article

Psoriatic arthritis and psoriasis: State of the art review and research advancesMEASE, P. J; GLADMAN, D. D; KRUEGER, G. G et al.Annals of the rheumatic diseases. 2005, Vol 64, issn 0003-4967, 119 p., SUP2Serial Issue

Classification and diagnostic criteria for psoriatic arthritisHELLIWELL, P. S; TAYLOR, W. J.Annals of the rheumatic diseases. 2005, Vol 64, pp ii3-ii8, issn 0003-4967, SUP2Article

Immunopathology of psoriasis and psoriatic arthritisVEALE, D. J; RITCHLIN, C; FITZGERALD, O et al.Annals of the rheumatic diseases. 2005, Vol 64, pp ii26-ii29, issn 0003-4967, SUP2Article

Genetic epidemiology of psoriasis and psoriatic arthritis. DiscussionRAHMAN, P; ELDER, J. T; RITCHLIN, C et al.Annals of the rheumatic diseases. 2005, Vol 64, pp ii37-ii41, issn 0003-4967, SUP2Article